Clinical Stage Pharmaceuticals

Aerie Pharmaceuticals Inc (NASDAQ: AERI), a clinical-stage pharmaceutical company that focuses on the treatment of glaucoma and other diseases of the eye, announced on Monday that it has successfully began dosing the first patients enrolled in Mercury 2, the company's second Phase 3 registration...